Anteris Boosts DurAVR Program with Inclusion in ASX 300

Anteris announced progress on its DurAVR program. The company said the program will benefit from its recent inclusion in the ASX 300 index. The ASX 300 expansion reflects broader market recognition of Anteris. DurAVR is a key development focus for the firm. Joining the ASX 300 may improve the program’s access to capital. Kalkine Media reported the announcement. The move positions Anteris among larger listed entities. Stakeholders will watch how the expansion influences DurAVR’s timeline.